Anna V. S.
- Country
- Spain
- Department
- KIDNEY AND PANCREAS TRASPLANT UNIT
Research Overview
- Evaluation of Autologous Tolerogenic Dendritic Cells in Highly Sensitized Patients Undergoing Kidney Transplantation
- Evaluation of Tegoprubart Versus Tacrolimus in Prophylaxis of Renal Allograft Rejection in Kidney Transplant Recipients
- Phase 2 Study of Empasiprubart in Deceased Donor Renal Allograft Recipients at Risk for Delayed Graft Function
Data & Insights
Has run more than one trial at 13 of 36 partner sites.
Specializations
Transplant Medicine
This investigator specializes in kidney transplantation with particular emphasis on improving outcomes for transplant recipients. Their research encompasses innovative approaches to graft function optimization and prevention of complications.
- Deceased donor kidney transplants
- Delayed graft function prevention
- Pre-emptive treatment strategies
The investigator focuses on developing advanced protocols for transplant recipient care and monitoring.
Immunosuppression Management
A key area of expertise includes the study of novel immunosuppressive therapies and their optimization in transplant recipients. The investigator explores innovative approaches to preventing allograft rejection.
- Tacrolimus dosing optimization
- Novel immunosuppressive agents
- Long-term immunosuppression safety
Research activities focus on personalizing immunosuppressive regimens through pharmacogenetic approaches.
Clinical Innovations
The investigator works on developing therapeutic strategies for improving transplant outcomes through novel treatment approaches and personalized medicine applications.
- Pharmacogenetic strategies
- Novel therapeutic agents
- Treatment optimization protocols
Their work encompasses both immediate post-transplant care and long-term outcome optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.